Table 3.
Characteristics | n | Relevant expression of miR-182-5p (log2x) | |||
---|---|---|---|---|---|
Mean ± SD | t/F-value | P-value | |||
Tissue | LUAD | 448 | 14.273 ± 0.947 | 17.368 | < 0.001* |
Noncancerous | 45 | 11.644 ± 1.160 | |||
Gender | Male | 209 | 14.259 ± 0.902 | −0.306 | 0.760 |
Female | 239 | 14.286 ± 0.987 | |||
Age(years) | ≤50 | 33 | 14.295 ± 1.205 | 0.175 | 0.862 |
> 50 | 396 | 14.257 ± 0.932 | |||
T | T1 + T2 | 388 | 14.294 ± 0.954 | 0.679 | 0.497 |
T3 + T4 | 57 | 14.203 ± 0.871 | |||
Nodes | No | 293 | 14.252 ± 0.966 | −1.025 | 0.306 |
Yes | 146 | 14.349 ± 0.892 | |||
Metastasis | No | 285 | 14.326 ± 0.898 | −0.366 | 0.715 |
Yes | 19 | 14.404 ± 1.027 | |||
Pathologic stage | I-II | 351 | 14.249 ± 0.958 | −0.810 | 0.419 |
III-IV | 92 | 14.340 ± 0.918 | |||
Anatomic neoplasm subdivision | L-Lower | 70 | 14.229 ± 0.825 | 0.512a | 0.727 |
L-Upper | 108 | 14.206 ± 0.998 | |||
R-Lower | 85 | 14.214 ± 0.940 | |||
R-Middle | 18 | 14.281 ± 0.789 | |||
R-Uppr | 155 | 14.351 ± 0.986 | |||
Tumor location | Peripheral | 113 | 14.309 ± 0.940 | −0.743 | 0.459 |
Central | 54 | 14.429 ± 1.051 |
LUAD: lung adenocarcinoma; SD: standard deviation
a One-way analysis of variance (ANOVA) was performed
* The results were statistically significant (P < 0.05)